Recent

% | $
Quotes you view appear here for quick access.

Oshkosh Corporation Message Board

delmur 1 post  |  Last Activity: Apr 21, 2015 9:54 AM Member since: Jun 7, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • delmur delmur Apr 21, 2015 9:54 AM Flag

    I'm wondering if you read this? Inovio Pharma and Roche (RHHBY) initiate clinical trial for Inovio's DNA immunotherapy to treat chronic hepatitis b infection (INO) : Inovio Pharmaceuticals (INO) announced that it has initiated a phase I trial to evaluate Inovio's DNA immunotherapy in patients who are chronically infected with hepatitis B. In 2013, Roche (RHHBY) and Inovio entered into a partnership to co-develop and commercialize Inovio's hepatitis B immunotherapy. This trial initiation triggers a $3 million milestone payment from Roche to Inovio.

OSK
41.34-0.33(-0.79%)Jul 6 4:04 PMEDT